Inhibición de la angiogénesis: - page 23

PFS (Adenocarcinoma): Benefit consistent

in subgroup analyses

Reck M, et al.

Lancet Oncol

2014;15:143–155.

SEO Version

Warning.

You are currently viewing the SEO version of !text.
It has a number of design and functionality limitations.

We recommend viewing the Flash version or the basic HTML version of this publication.

1...,13,14,15,16,17,18,19,20,21,22 24,25,26,27,28,29,30,31,32,33,...57